Double trouble for triple-negative breast cancer: Two-pronged strategy restores immunotherapy sensitivity
A team of MUSC Hollings Cancer Center researchers has discovered one way in which triple-negative breast cancer (TNBC) cells become resistant to immunotherapy and have tested a two-pronged treatment strategy that was able ...
Sep 9, 2024
0
66